Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Completed 12Terminated 5Unknown 3Recruiting 3Active not recruiting 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1

Conditions

Helicobacter Infections 1Chemotherapy Effect 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Clarithromycin × Clear all
NCT07341100 2026-05-11

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 2 Recruiting
20 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡